Publications

Export 173 results:
[ Author(Asc)] Title Type Year
Filters: First Letter Of Last Name is B  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
B
Bischoff AR, Pokhvisneva I, Léger É, Gaudreau H, Steiner M, Kennedy JL, O'Donnell K, Diorio J, Meaney MJ, Silveira PP.  2017.  Dynamic interaction between fetal adversity and a genetic score reflecting dopamine function on developmental outcomes at 36 months.. PLoS One. 12(5):e0177344.
Bimpisidis Z, König N, Stagkourakis S, Zell V, Vlcek B, Dumas S, Giros B, Broberger C, Hnasko TS, Wallén-Mackenzie Å.  2019.  The NeuroD6 Subtype of VTA Neurons Contributes to Psychostimulant Sensitization and Behavioral Reinforcement.. eNeuro. 6(3)
Bier N, Grenier S, Brodeur C, Gauthier S, Gilbert B, Hudon C, Lepage E, Ouellet M-C, Viscogliosi C, Belleville S.  2015.  Measuring the impact of cognitive and psychosocial interventions in persons with mild cognitive impairment with a randomized single-blind controlled trial: rationale and design of the MEMO+ study.. Int Psychogeriatr. 27(3):511-25.
Bhat V, Joober R, Sengupta SM.  2017.  How Environmental Factors Can Get Under the Skin: Epigenetics in Attention-Deficit/Hyperactivity Disorder.. J Am Acad Child Adolesc Psychiatry. 56(4):278-280.
Bhat V, Leong K, Lee J, Voineskos D, Daskalakis ZJ, Lam RW, Jollant F.  2014.  Research-track programs for residents in psychiatry: a review of literature and a report of 3 Canadian experiences.. Can J Psychiatry. 59(5):268-75.
Bhardwaj SK, Tse YChung, Ryan R, Wong TPan, Srivastava LK.  2014.  Impaired adrenergic-mediated plasticity of prefrontal cortical glutamate synapses in rats with developmental disruption of the ventral hippocampus.. Neuropsychopharmacology. 39(13):2963-73.
Bhardwaj SK, Ryan RT, Wong TPan, Srivastava LK.  2015.  Loss of dysbindin-1, a risk gene for schizophrenia, leads to impaired group 1 metabotropic glutamate receptor function in mice.. Front Behav Neurosci. 9:72.
Bhardwaj SK, Dodat F, Levesque D, Srivastava LK.  2018.  Altered regulation of Nur77 nuclear receptor gene expression in the mesocorticolimbic regions of rat brain by amphetamine sensitization.. Brain Res.
Bhardwaj SK, Stojkovic K, Kiessling S, Srivastava LK, Cermakian N.  2015.  Constant light uncovers behavioral effects of a mutation in the schizophrenia risk gene Dtnbp1 in mice.. Behav Brain Res. 284:58-68.
Bhagwat N, Pipitone J, Winterburn JL, Guo T, Duerden EG, Voineskos AN, Lepage M, Miller SP, Pruessner JC, M Chakravarty M.  2016.  Manual-Protocol Inspired Technique for Improving Automated MR Image Segmentation during Label Fusion.. Front Neurosci. 10:325.
Besse C, Poremski D, Laliberté V, Latimer E.  2017.  Changes in the nature and intensity of stress following employment among people with severe mental illness receiving individual placement and support services: an exploratory qualitative study.. J Ment Health. 26(4):312-317.
Besse C, Poremski D, Laliberté V, Latimer E.  2018.  The meaning and experience of stress among supported employment clients with mental health problems.. Health Soc Care Community. 26(3):383-392.
Bernard-Gauthier V, Bailey JJ, Mossine AV, Lindner S, Vomacka L, Aliaga A, Shao X, Quesada CA, Sherman P, Mahringer A et al..  2017.  A Kinome-Wide Selective Radiolabeled TrkB/C Inhibitor for in Vitro and in Vivo Neuroimaging: Synthesis, Preclinical Evaluation, and First-in-Human.. J Med Chem. 60(16):6897-6910.
Bernard-Gauthier V, Aliaga A, Aliaga A, Boudjemeline M, Hopewell R, Kostikov A, Rosa-Neto P, Thiel A, Schirrmacher R.  2015.  Syntheses and evaluation of carbon-11- and fluorine-18-radiolabeled pan-tropomyosin receptor kinase (Trk) inhibitors: exploration of the 4-aza-2-oxindole scaffold as Trk PET imaging agents.. ACS Chem Neurosci. 6(2):260-76.
Bernard-Gauthier V, Mossine AV, Mahringer A, Aliaga A, Bailey JJ, Shao X, Stauff J, Arteaga J, Sherman P, Grand'Maison M et al..  2018.  Identification of [F]TRACK, a Fluorine-18-Labeled Tropomyosin Receptor Kinase (Trk) Inhibitor for PET Imaging.. J Med Chem. 61(4):1737-1743.
Berlim M, Van den Eynde F.  2014.  Repetitive transcranial magnetic stimulation over the dorsolateral prefrontal cortex for treating posttraumatic stress disorder: an exploratory meta-analysis of randomized, double-blind and sham-controlled trials.. Can J Psychiatry. 59(9):487-96.
Berlim M, McGirr A, Van den Eynde F, Fleck MPA, Giacobbe P.  2014.  Effectiveness and acceptability of deep brain stimulation (DBS) of the subgenual cingulate cortex for treatment-resistant depression: a systematic review and exploratory meta-analysis.. J Affect Disord. 159:31-8.
Berlim M, Van den Eynde F, Tovar-Perdomo S, Chachamovich E, Zangen A, Turecki G.  2014.  Augmenting antidepressants with deep transcranial magnetic stimulation (DTMS) in treatment-resistant major depression.. World J Biol Psychiatry. 15(7):570-8.
Berlim M, McGirr A, Santos NRodrigues, Tremblay S, Martins R.  2017.  Efficacy of theta burst stimulation (TBS) for major depression: An exploratory meta-analysis of randomized and sham-controlled trials.. J Psychiatr Res. 90:102-109.
Berlim M, van den Eynde F, Tovar-Perdomo S, Daskalakis ZJ.  2014.  Response, remission and drop-out rates following high-frequency repetitive transcranial magnetic stimulation (rTMS) for treating major depression: a systematic review and meta-analysis of randomized, double-blind and sham-controlled trials.. Psychol Med. 44(2):225-39.
Bergeron L, Smolla N, Berthiaume C, Renaud J, Breton J-J, St-Georges M, Morin P, Zavaglia E, Labelle R.  2017.  Reliability, Validity, and Clinical Utility of the Dominic Interactive for Adolescents-RevisedA DSM-5-Based Self-Report Screen for Mental Disorders, Borderline Personality Traits, and Suicidality.. Can J Psychiatry. 62(3):211-222.
Bergeron D, Flynn K, Verret L, Poulin S, Bouchard RW, Bocti C, Fülöp T, Lacombe G, Gauthier S, Nasreddine Z et al..  2017.  Multicenter Validation of an MMSE-MoCA Conversion Table.. J Am Geriatr Soc. 65(5):1067-1072.
Benoit A, Harvey P-O, Bherer L, Lepage M.  2016.  Does the Beck Cognitive Insight Scale Predict Response to Cognitive Remediation in Schizophrenia? Schizophr Res Treatment. 2016:6371856.
Benoit A, Bowie CR, Lepage M.  2017.  Is cognitive insight relevant to functional capacity in schizophrenia? Schizophr Res. 184:150-151.
Benoit A, Bodnar M, Malla AK, Joober R, Bherer L, Lepage M.  2014.  Changes in memory performance over a 12-month period in relation to achieving symptomatic remission after a first-episode psychosis.. Schizophr Res. 153(1-3):103-8.

Pages